STOCK TITAN
  1. Home
  2. Sec-filings
  3. INNV
  4. [Form 4] InnovAge Holding Corp. Insider Trading Activity

InnovAge (INNV) director receives 8,539 RSUs vesting in 2027

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CARLSON JAMES G reported acquisition or exercise transactions in this Form 4 filing.

InnovAge Holding Corp. director James G. Carlson received an equity grant in the form of 8,539 Restricted Stock Units (RSUs), which cost him $0.00 per unit. These RSUs will be settled in shares of common stock and vest in full on June 30, 2027, subject to his continued service with the company.

Following this grant, Carlson directly holds a total of 95,889 shares or share-equivalents of InnovAge common stock, reflecting routine, compensation-related alignment with shareholders rather than an open-market purchase.

Positive

  • None.

Negative

  • None.
Insider CARLSON JAMES G
Role Director
Type Security Shares Price Value
Grant/Award Common Stock, $0.001 par value 8,539 $0.00 --
Holdings After Transaction: Common Stock, $0.001 par value — 95,889 shares (Direct)
Footnotes (1)
  1. [object Object]
RSUs granted 8,539 units Restricted Stock Units awarded to director on July 1, 2026
Grant price per RSU $0.00 per unit Equity compensation award, non-cash
Holdings after transaction 95,889 shares Total direct InnovAge equity position following RSU grant
Vesting date June 30, 2027 RSUs vest in full on this date, subject to continued service
Restricted Stock Units ("RSUs") financial
"Represented Restricted Stock Units ("RSUs") which will be settled in shares of common stock"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
continued service financial
"will vest in full on June 30, 2027, subject to the Reporting Person's continued service"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What did InnovAge (INNV) director James G. Carlson report in this Form 4?
James G. Carlson reported receiving 8,539 Restricted Stock Units (RSUs) of InnovAge common stock. The RSUs were granted at $0.00 per unit as equity compensation, increasing his total direct holdings to 95,889 shares or share-equivalents in the company.

Is James G. Carlson buying or selling InnovAge (INNV) stock in this filing?
This filing shows an acquisition through a grant, not a market buy or sale. Carlson received 8,539 RSUs as compensation, with no cash purchase price, adding to his equity position without any open-market trading activity disclosed.

When do the 8,539 InnovAge (INNV) RSUs granted to James G. Carlson vest?
The 8,539 RSUs granted to Carlson vest in full on June 30, 2027. Vesting is conditioned on his continued service with InnovAge, meaning he must remain with the company through that date to receive the underlying shares.

How many InnovAge (INNV) shares does James G. Carlson hold after this RSU grant?
After the RSU grant, Carlson holds 95,889 shares or share-equivalents of InnovAge common stock directly. This total includes the newly awarded 8,539 RSUs that will convert into shares upon vesting, aligning his compensation with the company’s long-term performance.

What is the nature of the 8,539 InnovAge (INNV) RSUs granted to James G. Carlson?
The 8,539 units are Restricted Stock Units that will be settled in InnovAge common stock. They were granted at a reported price of $0.00 per unit as a compensation award, vesting entirely on June 30, 2027, assuming Carlson’s continued service.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CARLSON JAMES G
(Last)(First)(Middle)
8950 E. LOWRY BOULEVARD
(Street)
DENVER COLORADO 80230
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
InnovAge Holding Corp. [ INNV ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, $0.001 par value07/01/2026A8,539(1)A$095,889D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represented Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2027, subject to the Reporting Person's continued service with the Issuer.
Remarks:
/s/ Nicole D'Amato, by Power of Attorney07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR